摘要
《KDIGO临床实践指南:肾移植受者的诊治》是肾移植领域第一个基于循证医学证据的临床实践指南,兼顾了不同国家经济、医疗水平的差异,对我国肾移植临床工作有较高的借鉴价值。我们从其中免疫抑制部分体会到以下几点:应重视我国肾移植领域循证医学证据的积累;重视免疫抑制剂的性价比及个体化用药,降低治疗费用;此外也应重视移植肾活组织检查,提高临床诊治水平。
Kidney Disease： Improving Global Outcomes （KDIGO） clinical practice guideline for the care of kidney transplant recipients is the first guideline based on clinical evidences in kidney transplant field. It takes into account the differences between developing and developed countries. Therefore, we believe that it could be a good reference for Chinese clinicians to manage our patients. In the article, we recommended to pay more attention to the data collection and management from our kidney transplant clinical practices, to emphasize on reasonable and individual use of inununosuppressive drugs to improve the cost effect ratio and to reduce the costs to the patients, and to value the use of renal allograft biopsy to improve diagnosis of rejection.
出处
《中华移植杂志（电子版）》
CAS
2010年第3期1-4,共4页
Chinese Journal of Transplantation(Electronic Edition)
基金
国家十一五科技支撑计划项目(2008BAI60B04)
关键词
肾移植
免疫抑制
循证医学
KDIGO
指南
Kidney transplantation
Immunosuppression
Evidence- based medicine
KDIGO
Guidelines
